Submit Deal
All corporates
Similar corporates
Summary
Vir Biotechnology is a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases.
Deals Overview
Market Context
All Corporates
Back to top
All rights reserved. Copyright © 2025 Datasite
Senior Management
George Scangos
CEO
Deals (1)
Service Providers
Relationships
Portfolio
Team
Sort
Target: VIR BIOTECHNOLOGY
Bidder: GLAXOSMITHKLINE PLC
3 Service Providers
2 Dealmakers
£ 203 M
Value
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy